ICiC Innovation Conference

Key information

Applications now Closed

For any questions please contact:

Research Strategy Coordinator
Dr Kimberley Trim 

ICiC Application Guidelines 2020 [download]ICiC Project plan form 2020 [download]

ICiC provides pilot funding to bridge the gap between discovery research and well-developed applications for MRC Developmental Pathway Funding Scheme (DPFS) support, or similar follow-on funding schemes.

Applications must be submitted via our online portal (enter via button on righthand side of this page).

There are two parts to the application, Part A is the online form we are using to gather various pieces of information on your project, and Part B requires various documentation to be uploaded via the online form.

Part A – PI details, ethics and IP

  • PI and co-investigator details
  • Details of collaborators
  • Details of industry partners (if applicable)
  • Project title, modality and research area
  • IP Information
  • Home office licence
  • Ethics

At the end of the first part of the online form you will be asked to upload the material below

Part B – Research plan details and approvals (upload via online form)

  • ICiC Project plan form 2020 (Word)
  • The InfoEd recovery page
    • Plus Royal Marsden costs (where applicable)
  • Email of costings approval from JRO
    • Plus Royal Marsden (where applicable)
  • HoD approval email
    • Plus Royal Marsden Clinical Research Lead approval (where applicable)

Frequently asked questions

Who is eligible to apply?

Any researcher from within the Imperial Academic Health Science Centre (i.e. anyone undertaking research within the partnership of Imperial College London and Imperial College Healthcare NHS Trust) that holds a contract extending to at least the end of the proposed project, and has departmental approval, is eligible to apply. For this call Royal Marsden (RM) employees may also apply as lead applicants providing they have an Imperial College co-applicant. Royal Marsden employees may be co-applicants on proposals led by Imperial staff.

Do I have to be based at a clinical campus?

No, this call is open to all eligible researchers irrespective of site, as long as the project is focussed on progressing new therapeutics/diagnostics/devices.

What is the difference between the MRC Confidence in Concept and the other funds?

The first represents an award from the MRC to provide pilot funding to bridge the potential gap between discovery research and well-developed applications for DPFS support. The remit of the MRC Confidence in Concept fund includes novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies. The NIHR Imperial BRC Therapeutic Primer Fund is to support the discovery and development of new therapeutics only. The Wellcome Trust Imperial ISSF fund can support all types of multidisciplinary application with the stipulation that it falls within the Wellcome Trust remit. Funds from The Royal Marsden will only fund joint projects between Imperial and Royal Marsden employees. It is anticipated that all supported projects will evolve into applications to DPFS/DCS or similar follow-on funding schemes.

Can Imperial employees (or ICHT employees with honorary College contracts) working on the Brompton, Marsden or Chelsea & Westminster campuses apply?

The MRC component is open to anyone with an Imperial College contract, honorary or otherwise. This is the fourth year that The Royal Marsden has contributed funds to this scheme and as such collaborative applications are encouraged. Previous schemes have involved an element of funding from the Chelsea & Westminster Hospital NHS Foundation Trust and therefore collaborative applications between Chelsea & Westminster and Imperial are also encouraged.

Can ICR employees with honorary Marsden contracts apply for this funding?

This year ICR has received an MRC Confidence in Concept award. As a consequence, for this call the ICR employed researchers are not eligible to apply for the Imperial Confidence in Concept Scheme, but are encouraged to submit projects aiming to speed up translation of discovery/fundamental science into new therapeutic approaches to the ICR Confidence in Concept Scheme instead.

How should I cost my proposal?

Applicants should use InfoEd to assist with costing their proposals and if there are any queries about this, they should email confidenceinconcept@imperial.ac.uk or contact Julie Williams (j.williams@imperial.ac.uk) or Ra Chitnavis (r.chitnavis@imperial.ac.uk), the JRO contacts for this scheme. Applicants should select ‘internal scheme’ as the funder.

In addition, collaborations between Imperial and the Royal Marsden researchers must contact BRCfinance@rmh.nhs.uk prior to submission to their proposals assist with costing.

It is vital to accurately cost proposals so that the research will not be impeded by resource constraints. This involves accurately costing all the staff effort and other direct costs required to deliver the research project, including a realistic view of investigator time.

What can I include in costs?

Projects should be costed as FEC projects including staffing and outsourcing costs. No indirect or directly allocated costs will be supported.

Outsourced contract work is permissible and should be fully costed and supported with a reasonable justification for using that supplier/collaborator. Where more than one supplier is available, the presentation of quotations acquired would be welcomed.

Generally, it is envisaged that this budget will not cover the recruitment of new staff. Directly incurred staff costs are permissible, however these are not standard research grants, but are milestone-driven grants designed to prove concepts/”prime” an idea (to facilitate successful projects applying for further translational funding from research funding bodies such as the MRC in the future). The Scheme Committee has the authority to cease project funding in the event that project milestones are not met. Therefore applicants are advised that employing staff on contracts beyond the term of a milestone is at their own risk (the grant will not allow funds for redundancy should the project be terminated).

All budget items must be justifiable and candidates invited to submit a full application will be asked to discuss the budget at the full application meeting. Budget items that cannot be justified will not be approved/included in the award and re-working of budgets may be requested post-meeting.

It is envisaged that project awards will be for 100% of the directly incurred costs only. This is shown in InfoEd by selecting the “charity” rule on the recovery page after completing the finance section.

Can I request a no-cost extension if needed?

Due to the restrictions on our award from the MRC all projects must be completed by May 2022; no extension requests will be granted. We advise applicants to have staff already in place to prevent recruitment delaying the project start date.

Can I include capital equipment in costs?

Given the size of the grants, it is not anticipated that capital equipment will form part of the grants.  However, if applicants make a justifiable, specific case these items may be considered up to a maximum of £10K. NIHR Imperial BRC funded projects and the Royal Marsden funded projects are limited to £5K per item of capital expenditure.

Can I include co-applicants from outside of Imperial?

Only co-applicants from The Royal Marsden or Chelsea & Westminster Hospital may be included. Activities can be outsourced, but these should be Imperial-led projects. Researchers from The Royal Marsden may also be lead applicant on proposals providing they have an Imperial co- applicant. Other academics or industry partners may be included as collaborators on the application.

Do I need to discuss the application with the relevant technology transfer team before applying?

We strongly recommend that applicants contact technology transfer specialists in the College’s Industry Partnership and Commercialisation (IPC) team before submitting an expression of interest, to discuss market potential analysis and any arising IP. Please contact Jon Wilkinson (jonathan.wilkinson@imperial.ac.uk), IPC Senior Executive or Stephanie Morris (stephanie.morris@imperial.ac.uk), IPC Director for the Faculty of Medicine.

Please note that, as of 1 March 2019, tech transfer work is now led directly by the College. This replaces the external technology transfer office arrangement that was previously in place.

Who forms the Scheme Committee?

The Scheme Committee is composed of representatives from Imperial Innovations, Imperial College Faculties of Medicine, Engineering and Natural Sciences, external experts and The Royal Marsden.

What is the balance of the projects being supported?

With the funding originating from HEFCE, MRC, NIHR Imperial BRC, Wellcome Trust ISSF, The Royal Marsden Foundation Trust the scheme looks to support a balanced portfolio of projects including both pre-clinical and clinical work elements.

Is project management mandatory?

Yes. The Scheme Committee recognise the importance of a centralised Project Manager who is familiar with all the projects and can facilitate, monitor and report progress to the Committee.

Who will decide which particular fund a project is supported by?

(e.g. Confidence in Concept fund, NIHR Imperial BRC/Imperial Innovations Therapeutic Primer Fund, Wellcome Trust ISSF, The Royal Marsden)

Applicants will apply through a single competition. The Selection Panel will determine the funding source of supported applications. Funding of the projects will be 100% of the directly incurred costs applied for.

NIHR Imperial BRC funded projects and the Royal Marsden funded projects will need to adhere to NIHR BRC contract terms and conditions, in particular concerning the ineligibility of costs relating to animal work, the limits on items of capital expenditure, intellectual property, the need to spend within NHS financial years, and requirements to meet clinical study performance metrics.

Will there be further calls for proposals?

Further MRC Confidence is Concept funding is dependent on a subsequent call from the MRC.